Pacira BioSciences (PCRX) EPS (Basic) Growth (3y) (2013 - 2026)
Pacira BioSciences (PCRX) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Pacira BioSciences | 939.59 Mn | 688.56 Mn | 148.24 Mn | -40.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.47% |
| Mar 31, 2026 | 29.46% |
| Dec 31, 2025 | 29.38% |
| Sep 30, 2025 | 116.57% |
| Jun 30, 2025 | -30.92% |
| Mar 31, 2025 | -11.92% |
| Dec 31, 2024 | 70.92% |
| Sep 30, 2024 | -114.23% |
| Jun 30, 2024 | -1.82% |
| Mar 31, 2024 | -6.41% |
| Dec 31, 2023 | 16.48% |
| Sep 30, 2023 | 154.64% |
| Jun 30, 2023 | 165.16% |
| Mar 31, 2023 | -89.63% |
| Dec 31, 2022 | -23.35% |
| Sep 30, 2022 | 56.44% |
| Jun 30, 2022 | 94.07% |
| Mar 31, 2022 | 91.77% |
| Dec 31, 2021 | -347.25% |
| Sep 30, 2021 | 146.23% |